nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CYP2C8—Omeprazole—Barrett's esophagus	0.238	0.361	CbGbCtD
Naloxone—CYP3A4—Esomeprazole—Barrett's esophagus	0.164	0.248	CbGbCtD
Naloxone—ABCB1—Omeprazole—Barrett's esophagus	0.161	0.244	CbGbCtD
Naloxone—CYP3A4—Omeprazole—Barrett's esophagus	0.0965	0.146	CbGbCtD
Naloxone—CREB1—exocrine gland—Barrett's esophagus	0.0135	0.334	CbGeAlD
Naloxone—Encephalopathy—Esomeprazole—Barrett's esophagus	0.00879	0.0548	CcSEcCtD
Naloxone—Encephalopathy—Omeprazole—Barrett's esophagus	0.00879	0.0548	CcSEcCtD
Naloxone—CREB1—epithelium—Barrett's esophagus	0.00589	0.145	CbGeAlD
Naloxone—CREB1—smooth muscle tissue—Barrett's esophagus	0.00568	0.14	CbGeAlD
Naloxone—Injection site reaction—Omeprazole—Barrett's esophagus	0.00561	0.035	CcSEcCtD
Naloxone—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00561	0.035	CcSEcCtD
Naloxone—CREB1—digestive system—Barrett's esophagus	0.00448	0.11	CbGeAlD
Naloxone—Hot flush—Esomeprazole—Barrett's esophagus	0.00438	0.0273	CcSEcCtD
Naloxone—Hot flush—Omeprazole—Barrett's esophagus	0.00438	0.0273	CcSEcCtD
Naloxone—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00434	0.0271	CcSEcCtD
Naloxone—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00434	0.0271	CcSEcCtD
Naloxone—Irritability—Omeprazole—Barrett's esophagus	0.00391	0.0244	CcSEcCtD
Naloxone—Irritability—Esomeprazole—Barrett's esophagus	0.00391	0.0244	CcSEcCtD
Naloxone—Depression—Omeprazole—Barrett's esophagus	0.00315	0.0196	CcSEcCtD
Naloxone—Depression—Esomeprazole—Barrett's esophagus	0.00315	0.0196	CcSEcCtD
Naloxone—Hallucination—Omeprazole—Barrett's esophagus	0.00282	0.0176	CcSEcCtD
Naloxone—Hallucination—Esomeprazole—Barrett's esophagus	0.00282	0.0176	CcSEcCtD
Naloxone—Flushing—Omeprazole—Barrett's esophagus	0.00263	0.0164	CcSEcCtD
Naloxone—Flushing—Esomeprazole—Barrett's esophagus	0.00263	0.0164	CcSEcCtD
Naloxone—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00255	0.0159	CcSEcCtD
Naloxone—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00255	0.0159	CcSEcCtD
Naloxone—Chills—Omeprazole—Barrett's esophagus	0.00254	0.0159	CcSEcCtD
Naloxone—Chills—Esomeprazole—Barrett's esophagus	0.00254	0.0159	CcSEcCtD
Naloxone—Mental disorder—Omeprazole—Barrett's esophagus	0.00248	0.0155	CcSEcCtD
Naloxone—Mental disorder—Esomeprazole—Barrett's esophagus	0.00248	0.0155	CcSEcCtD
Naloxone—Tension—Esomeprazole—Barrett's esophagus	0.00242	0.0151	CcSEcCtD
Naloxone—Tension—Omeprazole—Barrett's esophagus	0.00242	0.0151	CcSEcCtD
Naloxone—Nervousness—Esomeprazole—Barrett's esophagus	0.0024	0.0149	CcSEcCtD
Naloxone—Nervousness—Omeprazole—Barrett's esophagus	0.0024	0.0149	CcSEcCtD
Naloxone—ESR1—epithelium—Barrett's esophagus	0.00232	0.0571	CbGeAlD
Naloxone—Tremor—Omeprazole—Barrett's esophagus	0.00231	0.0144	CcSEcCtD
Naloxone—Tremor—Esomeprazole—Barrett's esophagus	0.00231	0.0144	CcSEcCtD
Naloxone—Agitation—Omeprazole—Barrett's esophagus	0.00227	0.0141	CcSEcCtD
Naloxone—Agitation—Esomeprazole—Barrett's esophagus	0.00227	0.0141	CcSEcCtD
Naloxone—ESR1—smooth muscle tissue—Barrett's esophagus	0.00224	0.055	CbGeAlD
Naloxone—Hypertension—Esomeprazole—Barrett's esophagus	0.00213	0.0133	CcSEcCtD
Naloxone—Hypertension—Omeprazole—Barrett's esophagus	0.00213	0.0133	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00209	0.013	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00209	0.013	CcSEcCtD
Naloxone—SLCO1A2—digestive system—Barrett's esophagus	0.00208	0.0512	CbGeAlD
Naloxone—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00197	0.0123	CcSEcCtD
Naloxone—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00197	0.0123	CcSEcCtD
Naloxone—Tachycardia—Omeprazole—Barrett's esophagus	0.00197	0.0123	CcSEcCtD
Naloxone—Tachycardia—Esomeprazole—Barrett's esophagus	0.00197	0.0123	CcSEcCtD
Naloxone—Skin disorder—Omeprazole—Barrett's esophagus	0.00196	0.0122	CcSEcCtD
Naloxone—Skin disorder—Esomeprazole—Barrett's esophagus	0.00196	0.0122	CcSEcCtD
Naloxone—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00195	0.0121	CcSEcCtD
Naloxone—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00195	0.0121	CcSEcCtD
Naloxone—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00181	0.0113	CcSEcCtD
Naloxone—Paraesthesia—Omeprazole—Barrett's esophagus	0.00181	0.0113	CcSEcCtD
Naloxone—Dyspnoea—Esomeprazole—Barrett's esophagus	0.0018	0.0112	CcSEcCtD
Naloxone—Dyspnoea—Omeprazole—Barrett's esophagus	0.0018	0.0112	CcSEcCtD
Naloxone—ESR1—digestive system—Barrett's esophagus	0.00177	0.0435	CbGeAlD
Naloxone—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00174	0.0108	CcSEcCtD
Naloxone—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00174	0.0108	CcSEcCtD
Naloxone—Pain—Omeprazole—Barrett's esophagus	0.00172	0.0107	CcSEcCtD
Naloxone—Pain—Esomeprazole—Barrett's esophagus	0.00172	0.0107	CcSEcCtD
Naloxone—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00159	0.00992	CcSEcCtD
Naloxone—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00159	0.00992	CcSEcCtD
Naloxone—Abdominal pain—Omeprazole—Barrett's esophagus	0.00159	0.00992	CcSEcCtD
Naloxone—Body temperature increased—Omeprazole—Barrett's esophagus	0.00159	0.00992	CcSEcCtD
Naloxone—TLR4—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.00145	0.0104	CbGpPWpGaD
Naloxone—Asthenia—Esomeprazole—Barrett's esophagus	0.00144	0.00901	CcSEcCtD
Naloxone—Asthenia—Omeprazole—Barrett's esophagus	0.00144	0.00901	CcSEcCtD
Naloxone—TLR4—MyD88-independent cascade—RELA—Barrett's esophagus	0.00139	0.00996	CbGpPWpGaD
Naloxone—TLR4—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.00139	0.00995	CbGpPWpGaD
Naloxone—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00138	0.00859	CcSEcCtD
Naloxone—Diarrhoea—Omeprazole—Barrett's esophagus	0.00138	0.00859	CcSEcCtD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00136	0.00972	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.00128	0.00916	CbGpPWpGaD
Naloxone—Vomiting—Esomeprazole—Barrett's esophagus	0.00128	0.00798	CcSEcCtD
Naloxone—Vomiting—Omeprazole—Barrett's esophagus	0.00128	0.00798	CcSEcCtD
Naloxone—CREB1—miRNAs involved in DNA damage response—TP53—Barrett's esophagus	0.00127	0.00909	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.00126	0.00897	CbGpPWpGaD
Naloxone—TLR4—Activated TLR4 signalling—RELA—Barrett's esophagus	0.00125	0.00896	CbGpPWpGaD
Naloxone—Nausea—Omeprazole—Barrett's esophagus	0.0012	0.00746	CcSEcCtD
Naloxone—Nausea—Esomeprazole—Barrett's esophagus	0.0012	0.00746	CcSEcCtD
Naloxone—TLR4—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.00118	0.00842	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00118	0.00841	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.00114	0.00815	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—BMP4—Barrett's esophagus	0.00111	0.00795	CbGpPWpGaD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00109	0.00776	CbGpPWpGaD
Naloxone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00108	0.00775	CbGpPWpGaD
Naloxone—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00107	0.00764	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.00106	0.00759	CbGpPWpGaD
Naloxone—TLR4—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.00105	0.0075	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.001	0.00715	CbGpPWpGaD
Naloxone—CYP3A4—digestive system—Barrett's esophagus	0.000985	0.0243	CbGeAlD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000958	0.00684	CbGpPWpGaD
Naloxone—CREB1—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000931	0.00665	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000924	0.0066	CbGpPWpGaD
Naloxone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000917	0.00655	CbGpPWpGaD
Naloxone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000917	0.00655	CbGpPWpGaD
Naloxone—ABCB1—epithelium—Barrett's esophagus	0.000916	0.0226	CbGeAlD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00088	0.00628	CbGpPWpGaD
Naloxone—ESR1—Nuclear Receptors—PPARG—Barrett's esophagus	0.000847	0.00605	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000818	0.00584	CbGpPWpGaD
Naloxone—CREB1—SREBP signalling—PPARG—Barrett's esophagus	0.000803	0.00573	CbGpPWpGaD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.000712	0.00508	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TP53—Barrett's esophagus	0.000701	0.005	CbGpPWpGaD
Naloxone—ABCB1—digestive system—Barrett's esophagus	0.000697	0.0172	CbGeAlD
Naloxone—OPRD1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000697	0.00497	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000694	0.00495	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—CDKN2A—Barrett's esophagus	0.000683	0.00488	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000682	0.00487	CbGpPWpGaD
Naloxone—ESR1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000669	0.00478	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000667	0.00477	CbGpPWpGaD
Naloxone—ESR1—FOXM1 transcription factor network—CDKN2A—Barrett's esophagus	0.000658	0.0047	CbGpPWpGaD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000647	0.00462	CbGpPWpGaD
Naloxone—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000636	0.00454	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000611	0.00436	CbGpPWpGaD
Naloxone—CREB1—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000608	0.00434	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000608	0.00434	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000605	0.00432	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000589	0.0042	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000588	0.0042	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000582	0.00416	CbGpPWpGaD
Naloxone—CREB1—ATM Signaling Pathway—TP53—Barrett's esophagus	0.000581	0.00415	CbGpPWpGaD
Naloxone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000575	0.0041	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000572	0.00408	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000566	0.00404	CbGpPWpGaD
Naloxone—CREB1—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.00055	0.00393	CbGpPWpGaD
Naloxone—CREB1—LKB1 signaling events—TP53—Barrett's esophagus	0.000549	0.00392	CbGpPWpGaD
Naloxone—CREB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000545	0.00389	CbGpPWpGaD
Naloxone—CREB1—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000535	0.00382	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000533	0.00381	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.00053	0.00378	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000525	0.00375	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000516	0.00369	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000516	0.00369	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000516	0.00369	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000515	0.00368	CbGpPWpGaD
Naloxone—CREB1—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000507	0.00362	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000495	0.00353	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000492	0.00352	CbGpPWpGaD
Naloxone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00049	0.0035	CbGpPWpGaD
Naloxone—CREB1—MyD88-independent cascade—RELA—Barrett's esophagus	0.000487	0.00348	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000486	0.00347	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—PPARG—Barrett's esophagus	0.000484	0.00345	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000482	0.00344	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000472	0.00337	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000467	0.00334	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000467	0.00334	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—APC—Barrett's esophagus	0.000462	0.0033	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000461	0.00329	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000455	0.00325	CbGpPWpGaD
Naloxone—CREB1—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000438	0.00313	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000437	0.00312	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—SST—Barrett's esophagus	0.000436	0.00311	CbGpPWpGaD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000424	0.00302	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000412	0.00294	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00041	0.00293	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000408	0.00292	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000398	0.00284	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000396	0.00283	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000394	0.00281	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000394	0.00281	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000388	0.00277	CbGpPWpGaD
Naloxone—CREB1—DNA Damage Response—TP53—Barrett's esophagus	0.00038	0.00271	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—TP53—Barrett's esophagus	0.00038	0.00271	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000375	0.00268	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000371	0.00265	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000368	0.00263	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	0.000367	0.00262	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000367	0.00262	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—RELA—Barrett's esophagus	0.000361	0.00258	CbGpPWpGaD
Naloxone—ESR1—LKB1 signaling events—TP53—Barrett's esophagus	0.000359	0.00257	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—SST—Barrett's esophagus	0.000356	0.00254	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000351	0.00251	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000346	0.00247	CbGpPWpGaD
Naloxone—TLR4—Immune System—HGF—Barrett's esophagus	0.000342	0.00244	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000341	0.00244	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—RELA—Barrett's esophagus	0.00034	0.00243	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000327	0.00234	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000327	0.00234	CbGpPWpGaD
Naloxone—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000325	0.00232	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.00032	0.00229	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000319	0.00228	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—SST—Barrett's esophagus	0.000312	0.00223	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000306	0.00218	CbGpPWpGaD
Naloxone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000302	0.00216	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000293	0.00209	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—RELA—Barrett's esophagus	0.000283	0.00202	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.00028	0.002	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000271	0.00194	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—GAST—Barrett's esophagus	0.000267	0.00191	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—GAST—Barrett's esophagus	0.000266	0.0019	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000266	0.0019	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—SST—Barrett's esophagus	0.000264	0.00188	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—TP53—Barrett's esophagus	0.000261	0.00186	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000257	0.00184	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000251	0.00179	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.00025	0.00179	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000247	0.00177	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000243	0.00174	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000241	0.00172	CbGpPWpGaD
Naloxone—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000241	0.00172	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000238	0.0017	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000237	0.00169	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000235	0.00168	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GAST—Barrett's esophagus	0.000234	0.00167	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000229	0.00163	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000217	0.00155	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGES—Barrett's esophagus	0.000215	0.00153	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000212	0.00151	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—RELA—Barrett's esophagus	0.000208	0.00149	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000206	0.00147	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000201	0.00144	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—SST—Barrett's esophagus	0.000201	0.00144	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000201	0.00143	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.000201	0.00143	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000199	0.00142	CbGpPWpGaD
Naloxone—TLR4—Immune System—RELA—Barrett's esophagus	0.000198	0.00142	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GAST—Barrett's esophagus	0.000197	0.00141	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.00019	0.00136	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—SST—Barrett's esophagus	0.000183	0.00131	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000183	0.00131	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—SST—Barrett's esophagus	0.000183	0.0013	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000182	0.0013	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—SST—Barrett's esophagus	0.000176	0.00126	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000175	0.00125	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000175	0.00125	CbGpPWpGaD
Naloxone—CREB1—Disease—SLC9A1—Barrett's esophagus	0.000173	0.00123	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.00017	0.00121	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NR1I2—Barrett's esophagus	0.000169	0.00121	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000166	0.00119	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—PPARG—Barrett's esophagus	0.000166	0.00119	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP26A1—Barrett's esophagus	0.000163	0.00116	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—SST—Barrett's esophagus	0.00016	0.00114	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—Barrett's esophagus	0.00016	0.00114	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.00016	0.00114	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GAST—Barrett's esophagus	0.000158	0.00113	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GAST—Barrett's esophagus	0.000157	0.00112	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—Barrett's esophagus	0.000154	0.0011	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—SST—Barrett's esophagus	0.000149	0.00106	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000139	0.00099	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GAST—Barrett's esophagus	0.000138	0.000985	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—SST—Barrett's esophagus	0.000135	0.000966	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000135	0.000963	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—RELA—Barrett's esophagus	0.000135	0.000961	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000132	0.000939	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000128	0.000911	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000122	0.000873	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000122	0.000868	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.00012	0.000858	CbGpPWpGaD
Naloxone—CREB1—Immune System—HGF—Barrett's esophagus	0.000119	0.000852	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—RELA—Barrett's esophagus	0.000119	0.000848	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—SLC9A1—Barrett's esophagus	0.000117	0.000837	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GAST—Barrett's esophagus	0.000117	0.000833	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000116	0.000826	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—RELA—Barrett's esophagus	0.000114	0.000815	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000109	0.000778	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SST—Barrett's esophagus	0.000108	0.000773	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SST—Barrett's esophagus	0.000108	0.00077	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000107	0.000765	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGES—Barrett's esophagus	0.000105	0.000753	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGES—Barrett's esophagus	0.000105	0.000748	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GAST—Barrett's esophagus	0.000103	0.000738	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000103	0.000734	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9.69e-05	0.000692	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SST—Barrett's esophagus	9.46e-05	0.000675	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	9.45e-05	0.000675	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGES—Barrett's esophagus	9.19e-05	0.000656	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HGF—Barrett's esophagus	9e-05	0.000642	CbGpPWpGaD
Naloxone—CREB1—Disease—APC—Barrett's esophagus	8.18e-05	0.000584	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SST—Barrett's esophagus	8e-05	0.000571	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	7.99e-05	0.00057	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP26A1—Barrett's esophagus	7.94e-05	0.000567	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CXCL8—Barrett's esophagus	7.84e-05	0.000559	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CXCL8—Barrett's esophagus	7.14e-05	0.00051	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CXCL8—Barrett's esophagus	7.12e-05	0.000508	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SST—Barrett's esophagus	7.09e-05	0.000506	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	6.96e-05	0.000497	CbGpPWpGaD
Naloxone—CREB1—Immune System—RELA—Barrett's esophagus	6.92e-05	0.000494	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CXCL8—Barrett's esophagus	6.87e-05	0.000491	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL8—Barrett's esophagus	6.24e-05	0.000445	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—Barrett's esophagus	6.21e-05	0.000443	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.9e-05	0.000421	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.87e-05	0.000419	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	5.81e-05	0.000415	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.77e-05	0.000412	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	5.76e-05	0.000411	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC9A1—Barrett's esophagus	5.73e-05	0.000409	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APC—Barrett's esophagus	5.73e-05	0.000409	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APC—Barrett's esophagus	5.71e-05	0.000408	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGES—Barrett's esophagus	5.66e-05	0.000404	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—PPARG—Barrett's esophagus	5.57e-05	0.000397	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PPARG—Barrett's esophagus	5.35e-05	0.000382	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	5.27e-05	0.000376	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	5.02e-05	0.000358	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APC—Barrett's esophagus	5.01e-05	0.000357	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.64e-05	0.000332	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.62e-05	0.00033	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RELA—Barrett's esophagus	4.47e-05	0.000319	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RELA—Barrett's esophagus	4.46e-05	0.000318	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	4.29e-05	0.000306	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APC—Barrett's esophagus	4.23e-05	0.000302	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL8—Barrett's esophagus	4.22e-05	0.000301	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—Barrett's esophagus	4.21e-05	0.000301	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL8—Barrett's esophagus	4.2e-05	0.0003	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RELA—Barrett's esophagus	3.91e-05	0.000279	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APC—Barrett's esophagus	3.75e-05	0.000268	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL8—Barrett's esophagus	3.69e-05	0.000263	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RELA—Barrett's esophagus	3.31e-05	0.000236	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL8—Barrett's esophagus	3.11e-05	0.000222	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.09e-05	0.000221	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—Barrett's esophagus	3.02e-05	0.000216	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RELA—Barrett's esophagus	2.93e-05	0.000209	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL8—Barrett's esophagus	2.76e-05	0.000197	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARG—Barrett's esophagus	2.63e-05	0.000188	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARG—Barrett's esophagus	2.61e-05	0.000187	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—Barrett's esophagus	2.59e-05	0.000185	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—Barrett's esophagus	2.58e-05	0.000184	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.29e-05	0.000164	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—Barrett's esophagus	2.26e-05	0.000161	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	2.07e-05	0.000148	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—Barrett's esophagus	2.06e-05	0.000147	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—Barrett's esophagus	1.91e-05	0.000136	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.8e-05	0.000129	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—Barrett's esophagus	1.69e-05	0.000121	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.41e-05	0.000101	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.11e-05	7.93e-05	CbGpPWpGaD
